Literature DB >> 6751824

Isolation and characterization of dipeptidyl peptidase IV from human placenta.

G Püschel, R Mentlein, E Heymann.   

Abstract

Human placenta is surprisingly rich in post-proline dipeptidyl peptidase activity. Among various cell fractions, microsomes have the highest specific activity. A homogeneous enzyme preparation is obtained in a six-step purification procedure. The final preparation appears homogeneous upon dodecyl sulfate electrophoresis, but analytical isoelectric focussing reveals various active bands with isoelectric points in the range of pH 3-4. The enzyme is a glycoprotein containing about 30% carbohydrate. Treatment with neuraminidase lowers the isoelectric points but does not reduce the heterogeneity of the band pattern. The subunit molecular weight is 120000 as estimated by dodecyl sulfate electrophoresis, whereas Mr of the native enzyme is greater than 200000, as can be concluded from gel filtration experiments. The purified dipeptidyl peptidase cleaves various synthetic and natural peptides, including substance P, kentsin, casomorphin and a synthetic renin inhibitor. In general, the specificity of the placenta peptidase is similar to that of post-proline dipeptidyl peptidase from other sources. Phenylalanylprolyl-beta-naphthylamide (Km = 0.02 mM, V = 92 U/mg) is the best substrate among various synthetic peptide derivatives. Only peptides with a free N-terminal amino group and proline, hydroxyproline, or alanine in position 2 of the N-terminal sequence are cleaved. However, X-Pro-Pro-. . . structures, e.g. as in bradykinin, are not attacked. 1 mM bis-(4-nitrophenyl)phosphate or 1 mM diisopropylfluorophosphate completely inactivate the peptidase within 30 min at 30 degrees C (pH 8). The peptidase is also completely inhibited by 1 mM Zn2+ and by other heavy metals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751824     DOI: 10.1111/j.1432-1033.1982.tb06788.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  17 in total

1.  Dipeptidyl peptidases in the soleus muscle of the rat before and after treatment with 5-hydroxytryptamine.

Authors:  P J Stoward; K N Christie; C Thomson
Journal:  Histochemistry       Date:  1988

2.  Dipeptidyl peptidase IV--subcellular localization, activity and kinetics in lymphocytes from control subjects, immunodeficient patients and cord blood.

Authors:  C Harland; T Shah; A D Webster; T J Peters
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

3.  Deficiency of membrane-bound dipeptidyl aminopeptidase IV in a certain rat strain.

Authors:  Y Watanabe; T Kojima; Y Fujimoto
Journal:  Experientia       Date:  1987-04-15

4.  Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function.

Authors:  G R Flentke; E Munoz; B T Huber; A G Plaut; C A Kettner; W W Bachovchin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

5.  Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.

Authors:  W G Gutheil; M Subramanyam; G R Flentke; D G Sanford; E Munoz; B T Huber; W W Bachovchin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

6.  Proteases in the human full-term placenta.

Authors:  R Gossrau; R Graf; M Ruhnke; C Hanski
Journal:  Histochemistry       Date:  1987

7.  Identification of cell surface dipeptidylpeptidase IV in human fibroblasts.

Authors:  M Saison; J Verlinden; F Van Leuven; J J Cassiman; H Van den Berghe
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

8.  The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism.

Authors:  Michael Engel; Torsten Hoffmann; Leona Wagner; Michael Wermann; Ulrich Heiser; Reiner Kiefersauer; Robert Huber; Wolfram Bode; Hans-Ulrich Demuth; Hans Brandstetter
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-10       Impact factor: 11.205

Review 9.  [Has dipeptidyl peptidase IV an effect on blood pressure and coagulation?].

Authors:  E Heymann; R Mentlein
Journal:  Klin Wochenschr       Date:  1984-01-02

10.  Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV.

Authors:  Jais R Bjelke; Jesper Christensen; Per F Nielsen; Sven Branner; Anders B Kanstrup; Nicolai Wagtmann; Hanne B Rasmussen
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.